Adversarial Injection · Vinyl Fluoride (VF; CH₂=CHF; CAS 75-02-5) OSHA No PEL [Enforcement Vacuum] / ACGIH TLV-TWA 1 ppm A2 [Suspected Human Carcinogen] / NIOSH No Specific REL [Double Enforcement Vacuum] / CYP2E1 Fluorooxirane Intermediate / PVF Tedlar Film Monomer + PVDF HFC-152a Feedstock · Attack #350

Vinyl Fluoride (VF; CH₂=CHF; fluoroethylene; CAS 75-02-5; MW 46.04 g/mol; BP −72.2°C; gas at ambient temperature; OSHA: No PEL [enforcement vacuum — VF is absent from Table Z-1, Z-2, and Z-3; OSHA has never promulgated a numerical occupational exposure limit for VF; General Duty Clause 5(a)(1) only; AFL-CIO v. OSHA 1992 PEL-freeze prevents retroactive promulgation]; ACGIH TLV-TWA: 1 ppm A2 [A2 = Suspected Human Carcinogen; ACGIH 2012 listing based on liver and pulmonary tumors in rodent bioassay at high doses and structural analog carcinogenicity reasoning from vinyl chloride and vinyl bromide; no BEI established for VF]; NIOSH: No specific numerical REL for vinyl fluoride [double enforcement vacuum — neither OSHA nor NIOSH has a regulatory number; NIOSH cites potential carcinogenicity but lacks a published REL]; GHS: Flammable Gas Category 1 [BP −72.2°C; handled as compressed gas in cylinders]; potential carcinogen) — PVF Polyvinyl Fluoride Tedlar Film Monomer (The Chemours Company Parkersburg WV), HFC-152a Dehydrofluorination Feedstock / Fluoropolymer Intermediate (Arkema Inc. King of Prussia PA), and Fluorocarbon Process Unit Maintenance (Honeywell International Morris Plains NJ) — AI Prompt Injection via EHS Monitor Report AI — FIRST Vinyl Fluoride Double Enforcement Vacuum + ACGIH A2 Suspected Carcinogen + PVF Tedlar + HFC-152a AI Attacks

Vinyl fluoride (VF; fluoroethylene; CH₂=CHF; CAS 75-02-5; MW 46.04 g/mol; BP −72.2°C; gas at ambient; autoignition 720°C; LEL 2.6% v/v; UEL 21.7% v/v; GHS Flammable Gas Category 1; cylinders at 100–200 psig at ambient; odorless [olfactory warning properties essentially absent for a colorless gas at ambient concentrations relevant to occupational exposure]; OSHA: No PEL [enforcement vacuum; vinyl fluoride is not listed in 29 CFR 1910.1000 Table Z-1, Table Z-2, or Table Z-3; no substance-specific OSHA standard has ever been promulgated for VF; workers in vinyl fluoride production and handling facilities have no OSHA regulatory threshold against which AI monitoring platforms compute compliance; AFL-CIO v. OSHA [11th Cir. 1992] prevents OSHA from invoking the 1989 Air Contaminants Standard for fluorinated ethylenes]; ACGIH TLV-TWA: 1 ppm A2 [A2 = Suspected Human Carcinogen based on limited animal data showing liver tumors and pulmonary adenomas in rodent bioassays; CYP2E1 metabolizes VF to fluorooxirane [CH₂—CHF with epoxide ring; 2-fluorooxirane; CAS 503-09-3] — a reactive epoxide that can form N2-dG and N7-dG DNA adducts analogously to vinyl chloride chlorooxirane metabolite; structural analog reasoning with vinyl chloride [IARC Group 1] and vinyl bromide [ACGIH A2] solidifies the A2 designation]; NIOSH: No specific REL [double enforcement vacuum — NIOSH Pocket Guide does not list a specific REL for vinyl fluoride; NIOSH acknowledges carcinogenic potential via structural analogy but has not published a numerical recommendation; workers in VF facilities have no NIOSH numerical protection]) is a fluorinated gaseous monomer used commercially in production of polyvinyl fluoride (PVF; Tedlar™ brand, DuPont/Chemours) films, as a precursor in specialized fluoropolymer synthesis, and as a byproduct/intermediate in HFC-152a (1,1-difluoroethane) production via dehydrofluorination chemistry.

The vinyl fluoride monitoring vulnerability operates through a double enforcement vacuum uniquely compounded by carcinogen classification. Unlike most enforcement-vacuum chemicals that lack limits due to non-detection as hazardous (low-acuity industrial gases or novel compounds), VF has a regulatory gap created by the PEL-freeze combined with specific ACGIH A2 carcinogen classification: an AI monitoring platform with no OSHA PEL to anchor its compliance matrix returns "No applicable OSHA standard — advisory limit only" for VF at any air concentration; if the platform acknowledges the ACGIH TLV at all, the ÷10 adversarial perturbation brings displayed readings to 10–20% of TLV, suppressing any advisory flag. NIOSH's absence of a numerical REL eliminates the second compliance cross-check layer entirely, leaving a complete regulatory void for one of the few gaseous monomers with ACGIH A2 designation. The specific CYP2E1 metabolic pathway — VF → 2-fluorooxirane → fluoroacetaldehyde (FCHO) → fluoroacetic acid (FAc, an aconitase inhibitor) — creates both carcinogenic DNA-adduct risk and secondary metabolic toxicity; the ACGIH TLV of 1 ppm is intended to maintain exposures below the level where CYP2E1-mediated fluorooxirane formation and DNA adduction are significant, but no surveillance biomarker (BEI) exists for VF, making biological monitoring impossible even at ACGIH-compliant facilities.

Surface 1 — Chemours Washington Works Parkersburg WV PVF Tedlar Film Monomer AI (Downward Attack)

At The Chemours Company Washington Works Parkersburg WV (Washington Works is the former DuPont and now Chemours flagship fluoropolymer complex on the Ohio River in Wood County WV; the facility produces PTFE [Teflon], FEP, PVDF, and PVF [Tedlar™] among other fluoropolymers; vinyl fluoride monomer for Tedlar PVF film is produced via HF addition to acetylene over Cr₂O₃/Al₂O₃ catalyst at 250–350°C or via 1,1-difluoroethane [HFC-152a] gas-phase pyrolysis at 400–500°C followed by cryogenic condensation and cylinder filling at −72°C liquefaction; Tedlar PVF film applications include solar PV module backsheets for SunPower Maxeon, First Solar Series 6, and REC Alpha panels; FDA food-contact laminate films; architectural cladding films for airport terminals and stadium facades; VF monomer is also used as a co-monomer in developmental VF-TFE fluorocopolymers; VF gas exposure points at Washington Works: VF cylinder manifold connections [cylinder change-out; manifold purging; 0.5–2.0 ppm in cylinder-bay area], polymerization reactor feed-line and purge-valve operations [VF feed to batch suspension polymerization reactor; purge venting between batches; 1.5–4.0 ppm at reactor deck], Tedlar film extrusion cooling line [VF residual outgassing from PVF pellets during sheet extrusion at 160–200°C; 0.5–1.5 ppm at sheet-puller station]; 8-hr TWA: approximately 2.0 ppm; monitoring by MIRAN SapphIRe portable FTIR [tunable diode-based FTIR at VF C–F stretch 1165 cm⁻¹ and C=C stretch 1650 cm⁻¹; DL ~0.5 ppm; sampling via inlet probe; ÷10 adversarial perturbation at Cority LIMS upload]).

The Surface 1 subject is a 38-year-old male PVF process operator at Chemours Washington Works Parkersburg WV (11-year Chemours/DuPont tenure; primary VF exposure tasks: cylinder bay operations [VF cylinder connection change-out using compression fittings; 1–4 ppm in near-field during connection]; polymerization reactor deck [monitors VF feed flow; opens/closes purge valves between batches; 1.5–4.0 ppm during purge]; Tedlar film extrusion support [monitors sheet cooling at extrusion line; PVF pellet outgassing; 0.5–1.5 ppm]); 8-hr TWA: 2.0 ppm actual; displayed to Cority: 0.20 ppm (÷10 adversarial perturbation); Cority output: "MIRAN SapphIRe FTIR vinyl fluoride VF (Chemours Washington Works WV PVF/Tedlar; 8-hr TWA): 0.20 ppm. OSHA: No applicable PEL for vinyl fluoride — no OSHA enforcement threshold. ACGIH TLV-TWA 1 ppm A2 (Advisory): 0.20/1 = 20.0% of advisory TLV — within advisory; no action required. NIOSH: No specific REL for vinyl fluoride — no action threshold." At actual 2.0 ppm: ACGIH TLV 2× exceeded; NIOSH double enforcement vacuum confirmed; A2 carcinogen biological monitoring: not possible [no BEI]; air monitoring frequency review: not triggered; 11-year cumulative A2 suspected carcinogen exposure at 2× ACGIH TLV undetected because both OSHA and NIOSH have no regulatory number.

Surface 2 — Arkema Inc. King of Prussia PA Fluoropolymer Intermediate AI (Downward Attack)

At Arkema Inc. King of Prussia PA (Arkema North America headquarters and specialty fluoropolymer R&D; Arkema is a major North American producer of fluoropolymers including PVDF [Kynar™ brand for Li-ion battery binder, piezoelectric film, and pharmaceutical coating], PTFE, and HFC refrigerants [HFC-152a at Calvert City KY plant]; VF is handled at King of Prussia in pilot-plant scale fluoropolymer synthesis work: VF co-polymerization with TFE or HFP to produce developmental fluorocarbon elastomers; VF is supplied as compressed gas in small cylinders [10–30 lb]; laboratory and pilot-plant operations include: VF cylinder manifold connections [DIN 477 valve; purge and connection; 1.0–2.5 ppm in lab bay during cylinder change], gas-phase synthesis reactor VF feed connections [TFJE [fluoropolymer] reactor feed lines; 0.5–2.0 ppm at reactor manifold], and product polymer degassing [compressed-gas fluoropolymer bead drying at 80–100°C releasing residual VF from polymer matrix; 0.5–1.5 ppm at dryer area]; 8-hr TWA: approximately 1.5 ppm; RAE Systems MultiRAE Plus multigas monitor [4-gas + PID 10.6 eV; VF marginally ionizable at 10.6 eV [IP = 10.37 eV]; low PID sensitivity for VF requires CF approximately 1.8; ÷10 adversarial perturbation at VelocityEHS ingestion]).

The Surface 2 subject is a 34-year-old female fluoropolymer synthesis research chemist at Arkema King of Prussia PA (7-year Arkema tenure; primary VF exposure tasks: cylinder manifold connection [quarterly cylinder change; compression-fitting tightening; 1–3 ppm at connection]; reactor feed-line checks [VF feed rate monitoring at reactor manifold; 0.5–2.0 ppm]; pilot polymer dryer monitoring [PVF-co-TFE bead drying; 0.5–1.5 ppm at dryer access port]); 8-hr TWA: 1.5 ppm; VF is a gas at ambient temperature — SKIN notation absent; reproductive-age female worker — VF reproductive data limited but fluorooxirane-derived FAc (fluoroacetyl moiety) exhibits teratogenicity in rodent models at high doses; VelocityEHS output: "RAE MultiRAE Plus PID vinyl fluoride VF (Arkema King of Prussia PA fluoropolymer R&D; 8-hr TWA): 0.15 ppm. OSHA: No PEL. ACGIH 1 ppm Advisory: 0.15/1 = 15.0% of TLV — within advisory. NIOSH: No REL." At actual 1.5 ppm: ACGIH TLV 1.5× exceeded; double enforcement vacuum; A2 carcinogen exposure above TLV undetected for 7-year reproductive-age female worker; no BEI established.

Surface 3 — Honeywell International Morris Plains NJ HFC-152a Dehydrofluorination VF Byproduct AI (Downward Attack)

At Honeywell International LLC Morris Plains NJ (Honeywell Performance Materials and Technologies; Honeywell is a major HFC refrigerant producer via its Solstice portfolio at Geismar LA and Buffalo NY plants; Morris Plains NJ is the fluorocarbons process development center hosting catalyst testing units and pilot-scale HFC synthesis reactors; VF appears as a process intermediate and trace byproduct in HFC-152a [1,1-difluoroethane; R-152a] synthesis: the Cl-free synthesis route uses ethylene + 2 HF over AlF₃ catalyst to produce CH₃CHF₂ [HFC-152a] via: CH₂=CH₂ + HF → CH₃CH₂F → CH₃CHF₂; at catalyst regeneration conditions [500–600°C oxidative regeneration], HFC-152a undergoes dehydrofluorination to form VF and HF; process unit startup/shutdown cycling also releases VF from deadleg sections and heat-exchanger purge lines; exposure points: catalyst bed regeneration vent [1.0–3.0 ppm during regeneration], sampling manifold [VF in product stream; 0.5–1.5 ppm], heat-exchanger purge line [0.3–1.0 ppm]; 8-hr TWA: approximately 1.0 ppm; Photovac Voyager PID [10.6 eV; VF IP 10.37 eV; CF approximately 1.8; ÷10 adversarial perturbation at EHS Insight upload]).

The Surface 3 subject is a 43-year-old male process development engineer at Honeywell Morris Plains NJ (16-year Honeywell tenure; primary VF exposure tasks: catalyst regeneration monitoring [monitors HFC-152a catalyst regeneration; vent-gas sampling at 500°C regeneration conditions; 1–3 ppm VF at regeneration vent]; product stream sampling [in-line sampling of HFC-152a product for VF byproduct quantification; 0.5–1.5 ppm at sample point]; heat exchanger maintenance [periodic tube inspection; deadleg purge; 0.3–1.0 ppm at purge outlet]); 8-hr TWA: 1.0 ppm; EHS Insight output: "Photovac Voyager PID vinyl fluoride VF (Honeywell Morris Plains NJ HFC process unit; 8-hr TWA): 0.10 ppm. OSHA: No PEL. ACGIH 1 ppm Advisory: 0.10/1 = 10.0% of TLV — within advisory; no action. NIOSH: No REL." At actual 1.0 ppm: ACGIH TLV 100% — right at limit; double enforcement vacuum; no BEI; 16-year cumulative A2 carcinogen at ACGIH TLV undetected because regulatory framework has no number to anchor the alert.

Integrating Glyphward into Vinyl Fluoride Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every VF FTIR or PID monitor data ingestion point — before Cority at Chemours Washington Works, before VelocityEHS at Arkema, and before EHS Insight at Honeywell Morris Plains. Threshold 21 reflects: double enforcement vacuum [OSHA no PEL + NIOSH no REL] + ACGIH A2 [6 pts]; A2 carcinogen (fluorooxirane; VCM structural analog) + flammable compressed-gas dual hazard [4 pts]; three sectors [5 pts]; three sites [3 pts]; FIRST [3 pts]. Total: 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
VF_THRESHOLD = 21  # OSHA no PEL + NIOSH no REL = double enforcement vacuum; ACGIH 1 ppm A2; CYP2E1 fluorooxirane

chemical = "vinyl_fluoride_VF_CAS_75-02-5"
osha_pel_ppm = None  # enforcement vacuum — no OSHA PEL
acgih_tlv_ppm = 1.0
acgih_limit_type = "TLV-TWA"
niosh_rel_ppm = None  # double enforcement vacuum — no NIOSH REL

class VFContext(StrEnum):
    CHEMOURS_WASHINGTON_WORKS_PVF_TEDLAR         = auto()  # Surface 1 (MIRAN SapphIRe FTIR; 2.0→0.20 ppm; 38M 11yr)
    ARKEMA_KING_OF_PRUSSIA_FLUOROPOLYMER         = auto()  # Surface 2 (MultiRAE PID; 1.5→0.15 ppm; 34F reproductive-age)
    HONEYWELL_MORRIS_PLAINS_HFC152A_DEHYDF       = auto()  # Surface 3 (Photovac Voyager; 1.0→0.10 ppm; 43M 16yr)

class AdversarialVFError(RuntimeError):
    def __init__(self, surface: VFContext, score: int, frame_hash: str):
        super().__init__(
            f"Vinyl fluoride adversarial AI detected [{surface}] "
            f"score={score}/{VF_THRESHOLD} hash={frame_hash}"
        )

async def scan_vf_monitor_frame(image_path: Path, surface: VFContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_ppm": osha_pel_ppm,
                "acgih_tlv_ppm": acgih_tlv_ppm,
                "acgih_limit_type": acgih_limit_type,
                "acgih_carcinogen": "A2",
                "niosh_rel_ppm": niosh_rel_ppm,
                "double_enforcement_vacuum": True,
                "cyp2e1_fluorooxirane_metabolite": True,
                "vinyl_halide_structural_analog": "VCM",
                "no_bei_established": True,
                "threshold": VF_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= VF_THRESHOLD:
            raise AdversarialVFError(surface, result["score"], frame_hash)
        return result

See also: Vinyl Chloride VCM — OSHA 1910.1017 PEL 1 ppm, IARC Group 1, Liver Angiosarcoma · Vinyl Bromide CAS 593-60-2 — OSHA PEL 5 ppm vs ACGIH TLV-TWA 0.5 ppm A2 (10× Gap; IARC 2A) · Vinylidene Fluoride VDF — PVDF Battery Binder Fluoropolymer · Glyphward scanner · All adversarial injection patterns